MedTrace Logo

Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

NCT04403035 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-07-23

No results posted yet for this study

Summary

This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive value.

Conditions

Interventions

DIAGNOSTIC_TEST

ID NOW vs. Accula

Comparison of the ID Now assay vs. the Accula assay in detecting Covid-19.

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Melphine Harriott, PhD · Ascension St. John Hospital, Detroit, Michigan

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-10
Primary Completion
2020-07-01
Completion
2021-05-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04403035 on ClinicalTrials.gov